Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. AbbVie Inc.
  6. News
  7. Summary
    ABBV   US00287Y1091

ABBVIE INC.

(ABBV)
  Report
Delayed Nyse  -  04:04 2022-11-30 pm EST
161.18 USD   +1.88%
11/29Transcript : AbbVie Inc. Presents at 5th Annual Evercore ISI HealthCONx Conference 2022, Nov-29-2022 10:55 AM
CI
11/29Rare success for Alzheimer's research unlocks hope for future therapies
RE
11/29Abbvie Inc. : Change in Directors or Principal Officers (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AbbVie to Host Third-Quarter 2022 Earnings Conference Call

10/04/2022 | 08:01am EST

NORTH CHICAGO, Ill., Oct. 4, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2022 financial results on Friday, October 28, 2022, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie's Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

 

Cision
View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-third-quarter-2022-earnings-conference-call-301639218.html

SOURCE AbbVie


ę PRNewswire 2022
All news about ABBVIE INC.
11/29Transcript : AbbVie Inc. Presents at 5th Annual Evercore ISI HealthCONx Confe..
CI
11/29Rare success for Alzheimer's research unlocks hope for future therapies
RE
11/29Abbvie Inc. : Change in Directors or Principal Officers (form 8-K)
AQ
11/28MarketScreener's World Press Review : November 28, 2..
MS
11/28North American Morning Briefing: Covid Protests in China Spread, Hit Market Se..
DJ
11/27News Highlights: Top Company News of the Day
DJ
11/25Sun Pharmaceutical's Psoriatic Arthritis Drug Up for Strong Sales Once Available
MT
11/24AbbVie Announces European Commission Approval of SKYRIZI for the Treatment of Moderate ..
AQ
11/24The Impact of Inaction - New Publication Reveals Not All of Canada is on Track to Meet ..
AQ
11/23Global markets live: UBS, Apple, Nordstrom, Autodesk, Vmware...
MS
More news
Analyst Recommendations on ABBVIE INC.
More recommendations